Amano Enzyme Inc.
USPTO PatentsView assignee record - 46 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Amano ranks #7,107 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 27 technology areas.
- #7,107
- of 49,997 US assignees by volume
- Top 25%
- by Innovation Score (44.7/100)
- 8.6
- avg claims per patent
- -17%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R7107 · Foreign Corporation #7,107 · 46 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 46 grants
- UPPER-Q #7,107/49,997
- PHOTO-FINISH Ab-kwekersrechten B V
- CPC-FOCUS C12N · 27 areas
- INNOV-PAR 44.7/100
- CLAIMS-PAR 8.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -17% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ab-kwekersrechten B.V. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Amano’s 44.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Amano
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Amano Enzyme · this assignee
Amano Enzyme · this assignee
45 score
- China International… · near
China International… · near
45 score
- Enlighted · near
Enlighted · near
45 score
- G&H Diversified… · near
G&H Diversified… · near
45 score
- Mapsted · near
Mapsted · near
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Amano's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Amano?
Each dot is one of Amano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amano’s own 8.6 claims/patent is at or below the 10.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Amano's grants concentrate
Amano Enzyme Inc. is a focused PatentsView assignee: 27 CPC subclasses with 87% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2024. By volume, Amano sits between inVia Robotics, Inc. and Ariel Scientific Innovations Ltd..
Amano's three-year grant acceleration
Amano Enzyme Inc. shows 13 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Amano's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- invia Robotics
inVia Robotics, Inc.
47 patents
- A U Vista
A.U. Vista, Inc.
46 patents
- Ab-kwekersrechten…
Ab-kwekersrechten B.V.
46 patents
- ACE
ACE Technologies Corporation
46 patents
- Ampere S
Ampere S.A.S.
46 patents
- Ankon Medical (Sh…
Ankon Medical Technologies (SHANGHAI) Co., Ltd.
46 patents
- Applied Invention
Applied Invention, LLC
46 patents
- Ariel Scientific…
Ariel Scientific Innovations Ltd.
46 patents
- Amano Enzyme ◀
Amano Enzyme Inc.
46 patents
What this shows Amano holds 46 patents at rank #7,107, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Amano
By rank, the assignees closest to #7,107 in granted patent volume.
- inVia Robotics, Inc. #7,103 · 47 patents
- A.U. Vista, Inc. #7,104 · 46 patents
- Ab-kwekersrechten B.V. #7,105 · 46 patents
- ACE Technologies Corporation #7,106 · 46 patents
- Ampere S.A.S. #7,108 · 46 patents
- Ankon Medical Technologies (SHANGHAI) Co., Ltd. #7,109 · 46 patents
- Applied Invention, LLC #7,110 · 46 patents
- Ariel Scientific Innovations Ltd. #7,111 · 46 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Amano's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Amano, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Amano ranks #259 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (45 here).
Amano's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 13.0% |
| 2016 | 8 | 17.4% |
| 2017 | 3 | 6.5% |
| 2018 | 3 | 6.5% |
| 2019 | 4 | 8.7% |
| 2020 | 2 | 4.3% |
| 2021 | 5 | 10.9% |
| 2022 | 7 | 15.2% |
| 2023 | 5 | 10.9% |
| 2024 | 1 | 2.2% |
| 2025partial year | 2 | 4.3% |
Which technologies does Amano Enzyme Inc. patent most?
Top 15 of 27 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Amano Enzyme Inc.'s patent record in context - here's where to go next.
- Amano Enzyme Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 87% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #7,107 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Amano Enzyme Inc. against inVia Robotics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.